EMAIL DETAILS

Evidence Based Performance: Vestex fluid barrier / antimicrobial impregnated
scrub uniforms combined with good hand hygiene reduces the burden of
Methicillin-Resistant Staphylococcus aureus (MRSA). The Virginia Commonwealth
University (VCU) study documents how Vestex may play a role in decreasing the
risk of MRSA transmission to patients.

Numerous [1]studies last year [2]confirmed the presence of high amounts of
bacteria on healthcare worker scrubs and lab coats. Led by [3]Gonzalo Bearman,
M.D., M.P.H., associate professor of internal medicine in the VCU School of
Medicine and associate hospital epidemiologist at the VCU Medical Center, the
study \u201c[4]A Crossover Trial of Antimicrobial Scrubs to Reduce
Methicillin-Resistant Staphylococcus Aureus Burden on Healthcare Worker
Apparel,\u201d will appear in the March issue of the Journal Infection Control and
Hospital Epidemiology.

According to Bearman\u2019s research, the Vestex [5]fluid barrier / [6]antimicrobial
scrubs had \u201ca statistically significant 4-7 log, (greater than a 99.99%),
decrease in the overall mean log CFU MRSA count (amount of MRSA on the scrubs)
compared to normal scrubs.

The Researchers Conclude: \u201cThe antimicrobial scrubs tested were associated with
decreased MRSA apparel microbial bioburden. When bundled with known infection
prevention strategies such as hand hygiene, antimicrobial impregnated apparel
may limit the bacterial burden of the inanimate environment. For settings with
high rates of hospital-acquired infections with drug-resistant pathogens such
as MRSA, the use of antimicrobial apparel may be a useful adjunct to other
infection prevention measures.\u201d

What Makes Vestex Different? Vestex uses a dual mode of action to prevent the
bacteria from being acquired and retained on the garment. The first mode of
action, [7]the fluid barrier, prevents organisms from being acquired on the
garment. As the infectious contaminants or fluids are repelled, the numbers of
organisms that remain on the fabric are significantly reduced. By reducing the
number of organisms retained on the garment there is a decrease in the exposure
time required for the [8]antimicrobial to take action.

Vestex Mission: \u201cWe know that scrubs and lab coats are contaminated with the
superbug MRSA and it puts workers and patients at risk,\u201d explains Ben Favret,
President and CEO of Vestagen. \u201cOur mission is to protect healthcare workers,
their patients and the community from the acquisition, retention and
transmission of these contaminants. Dr. Bearman\u2018s research builds upon the
scientific evidence documenting how well Vestex Active Barrier Protective
Apparel performs that mission.\u201d

Protection for All: \u201cOSHA reports that healthcare workers experience more
injury and illness than any other profession. Every healthcare worker around
the globe deserves Vestex protection,\u201d states Brian Crawford, Vestagen\u2019s Chief
Commercial Officer.

Vestex Active Barrier Protective Apparel is currently available online at
[9]www.vestexprotects.com

and in select uniform retail stores and websites. \u201cVestagen is also
partnering with leading uniform manufacturers and distributors around the globe
so healthcare workers can get the protection they need and the colors and
styles they want,\u201d adds Crawford.

About Vestagen Technical Textiles, LLC

Vestagen Technical Textiles is the leader in Active Barrier Protection. Based
in Orlando, Fla., Vestagen is led by a skilled management team with nearly a
century of combined experience in the health care, textile and apparel
industries. Backed by V-Ten Capital Partners, Vestagen is committed to
protecting healthcare workers and their patients. For more information, visit
[10]www.vestagen.com and [11]www.[12]v[13]estexprotects.com. Join the
conversation \u2013 \u201cLike\u201d Vestex on [14]Facebook, follow us on [15]Twitter and see
Vestex in Action on [16]YouTube.

Disclaimer

The ability of Vestex to reduce MRSA or other microbial bioburden on garments
has not been shown to correlate with any clinical event or to be able to reduce
patient infections. Clinical studies to evaluate reduction in infection have
not been performed. The antimicrobial agent used in Vestex is EPA registered
to guard against the degradation of the fabric from microorganisms and to
retard the growth and action of odor causing bacteria.

References

1. http://vestexprotects.com/system/pdfs/29/original/Burden_hili.pdf
2. http://www.vestexprotects.com/system/pdfs/28/original/wiener_well_2011_contam_uniforms_israel.pdf
3. http://www.people.vcu.edu/~gbearman/
4. http://www.jstor.org/pss/10.1086/664045
5. http://www.vestexprotects.com/technology/repels
6. http://www.vestexprotects.com/technology/kills
7. http://www.youtube.com/watch?feature=player_embedded&v=RBi5nabhskU
8. http://www.vestexprotects.com/technology/kills
9. http://www.vestexprotects.com/
10. http://www.vestagen.com/
11. http://www.vestexprotects.com/
12. http://www.vestexprotects.com/
13. http://www.vestexprotects.com/
14. http://www.facebook.com/#!/vestexprotects
15. http://twitter.com/cleancooldry
16. http://www.youtube.com/results?search_query=cleancooldry&aq=f

This message was sent to hbiden@senecaga.com from:
Vestagen Technical Textiles, LLC | 1301 W. Colonial Dr | Orlando, FL 32804

Unsubscribe:
http://app.icontact.com/icp/mmail-mprofile.pl?r=48406493&l=78796&s=O5L4&m=667503&c=303934

Forward To a Friend:
http://app.icontact.com/icp/core/message/forward?m=667503&s=48406493&c=O5L4&cid=303934